Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Rapid Micro Biosystems (RPID) Shares Outstanding (Diluted Average) (2020 - 2025)

Rapid Micro Biosystems' Shares Outstanding (Diluted Average) history spans 6 years, with the latest figure at $44.7 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 2.53% to $44.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $44.7 million, a 2.53% increase, with the full-year FY2025 number at $44.7 million, up 2.53% from a year prior.
  • Shares Outstanding (Diluted Average) hit $44.7 million in Q4 2025 for Rapid Micro Biosystems, roughly flat from $44.5 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for RPID hit a ceiling of $44.7 million in Q4 2025 and a floor of $641371.0 in Q1 2021.
  • Historically, Shares Outstanding (Diluted Average) has averaged $37.5 million across 5 years, with a median of $43.0 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): skyrocketed 9866.7% in 2021 and later grew 1.01% in 2024.
  • Tracing RPID's Shares Outstanding (Diluted Average) over 5 years: stood at $19.8 million in 2021, then skyrocketed by 114.59% to $42.5 million in 2022, then grew by 1.34% to $43.0 million in 2023, then rose by 1.28% to $43.6 million in 2024, then increased by 2.53% to $44.7 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for RPID at $44.7 million in Q4 2025, $44.5 million in Q3 2025, and $44.3 million in Q2 2025.